Background Guidelines recommend a trial of one or more antiarrhythmic drugs before
catheter ablation is considered in patients with atrial fibrillation. However, first-line ablation …

Background Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial
fibrillation are associated with increased risks of thromboembolism and heart failure …

Background In patients with symptomatic paroxysmal atrial fibrillation that has not
responded to medication, catheter ablation is more effective than antiarrhythmic drug …

Background Current guidelines recommend pulmonary-vein isolation by means of catheter
ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency …

Aim Cryoballoon ablation (Cryoballoon) has emerged as a new alternative for the treatment
of symptomatic drug-refractory atrial fibrillation (AF). Whether the results of Cryoballoon are …

Background: Advanced generation ablation technologies have been developed to achieve
more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial …

Atrial fibrillation (AF), the most common sustained arrhythmia observed in clinical practice, is
a chronic and progressive disorder characterized by exacerbations and remissions …

Aims Treatment guidelines for patients with atrial fibrillation (AF) suggest that patients should
be managed with an antiarrhythmic drug (AAD) before undergoing catheter ablation (CA) …

Objective The aim of this study was to evaluate the clinical efficacy and safety outcomes of
the treatment with cryoballoon (CB) compared to the treatment with traditional irrigated …

Aims Pulmonary vein isolation (PVI), the standard for atrial fibrillation (AF) ablation, is most
commonly applied with radiofrequency (RF) energy, although cryoballoon technology …